Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Unknown 3Completed 1

Sponsor Class

OTHER 1452INDUSTRY 798NIH 163NETWORK 118OTHER_GOV 33UNKNOWN 4INDIV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Lymphoid 1Head & Neck 1

Conditions

Sarcoma 1Nasopharyngeal Carcinoma 1Lymphoma, Extranodal NK-T-Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Paclitaxel 20Capecitabine 18S 1 (combination) 17Cisplatin 15Oxaliplatin 11Radiotherapy, Intensity-Modulated 9apatinib 8Epirubicin 8Docetaxel 8Carboplatin 8Radiotherapy 7Irinotecan 7titanium silicide 6sintilimab 6pyrotinib 6nimotuzumab 6anlotinib 6Drug Therapy 6Albumin-Bound Paclitaxel 6130-nm albumin-bound paclitaxel 6nedaplatin 5camrelizumab 5Temozolomide 5Etoposide 5Bevacizumab 5nabiximols 4Vinorelbine 4Trastuzumab 4Radiation Dose Hypofractionation 4Radiation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
UNKNOWN × Gemcitabine × Clear all
NCT05254899 2022-02-24

Anti-PD-1 Antibody and P-GEMOX Chemotherapy Combined With Radiotherapy in High-risk Early-Stage ENKTL

ChineseAMS

Phase 2 Unknown
54 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT03639467 2018-09-18

Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma

ChineseAMS

Phase 1/2 Unknown
40 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT00600587 2013-06-25

Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)

GuangdongPPH

Phase 2 Completed
24 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01812018 2013-03-15

Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma

ChineseAMS

Phase 2 Unknown
30 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡